Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials | Zendy

Maria Taboada | Zendy; David Melnick | Zendy; Joseph P. Iaconis | Zendy; Fang Sun | Zendy; Nan Zhong | Zendy; Thomas M. File | Zendy; Lily Llorens | Zendy; H. David Friedland | Zendy; David J. Wilson | Zendy

Open Access

Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials

Author(s) -

Maria Taboada,

David Melnick,

Joseph P. Iaconis,

Fang Sun,

Nan Zhong,

Thomas M. File,

Lily Llorens,

H. David Friedland,

David J. Wilson

Publication year - 2015

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv415

Subject(s) - ceftriaxone , medicine , meta analysis , randomized controlled trial , community acquired pneumonia , pneumonia , cephalosporin , intensive care medicine , antibiotics , microbiology and biotechnology , biology

We conducted a meta-analysis of clinical trials of adults hospitalized with pneumonia outcomes research team (PORT) risk class 3-4 community-acquired pneumonia (CAP) receiving ceftaroline fosamil versus ceftriaxone.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research